Clinical Trial

Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence

Study acronym: NOVOSTART
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the clinical efficacy of the LCPT En-varsus \[Life-Cycle Pharma Tacrolimus\] initiated in de novo (Day 0 of transplantation) using the Biopsy Proven Acute Re-jection and iBox (full and abbreviated algo-rithms).
Trial Details
NCT Number NCT06960824
Lead Sponsor Chiesi SAS
Conditions Chronic Renal Disease
Enrollment 165 participants
Start Date 2025-05
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-07